Back
Zevra Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
ZVRA
Zevra Therapeutics, Inc.
Last Price:
$8.66
Seasonality Move:
-1.31%
7 Day Trial
ALL ACCESS PASS
$
7
Zevra Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics, Inc. has on average historically fallen by 6.3% based on the past 10 years of stock performance.
-
Zevra Therapeutics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Zevra Therapeutics, Inc. Stock Undervalued?The current Zevra Therapeutics, Inc. [ZVRA] share price is $8.64. The Score for ZVRA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics, Inc. has on average historically fallen by 6.3% based on the past 10 years of stock performance.
Zevra Therapeutics, Inc. Stock Rating
Sell
44
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Is Zevra Therapeutics, Inc. overpriced?
-
Zevra Therapeutics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Zevra Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
13.16
52-Week Low:
6.19
Prediction Charts
Market Cap:
486.4M
Price in USD:
8.64
Volume:
635.5K
Beta:
1.82
Technical Analysis
SMA50:
9.34
SMA100:
9.38
SMA200:
9.13
52-Wk Change:
0.58%
Stock Predictions
-
Is Zevra Therapeutics, Inc. stock public?Yes, Zevra Therapeutics, Inc. is a publicly traded company.
-
What is the Zevra Therapeutics, Inc. stock quote today?The Zevra Therapeutics, Inc. stock price is 8.64 USD today.
-
How to buy Zevra Therapeutics, Inc. stock online?You can buy Zevra Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 8.65 | 8.71 | 8.79 | 8.52 |
| Dec-8 | 8.81 | 8.78 | 9.03 | 8.73 |
| Dec-9 | 8.76 | 8.58 | 8.93 | 8.51 |
| Dec-10 | 8.56 | 8.45 | 8.68 | 8.40 |
| Dec-11 | 8.48 | 8.39 | 8.58 | 8.31 |
| Dec-12 | 8.39 | 8.33 | 8.49 | 8.24 |
| Dec-15 | 8.40 | 8.17 | 8.58 | 8.13 |
| Dec-16 | 8.20 | 8.12 | 8.30 | 8.05 |
| Dec-17 | 8.13 | 8.11 | 8.32 | 8.06 |
| Dec-18 | 8.20 | 8.10 | 8.32 | 8.05 |
| Dec-19 | 8.02 | 8.31 | 8.40 | 8.01 |
| Dec-22 | 8.23 | 8.55 | 8.62 | 8.13 |
| Dec-23 | 8.55 | 8.53 | 8.65 | 8.29 |
| Dec-24 | 8.53 | 8.64 | 8.72 | 8.42 |
Zevra Therapeutics, Inc. Earnings
Zevra Therapeutics, Inc. Earnings Report: Per Share Zevra Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics, Inc. Forecast Revenue Growth
Zevra Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.09 per share, and a decrease next year of $0.54 per share.
* Zevra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.